| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0003 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |